BIOLARGO, INC. (BLGO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2M 4M 6M Q3 '21: 712K Q4 '21: 788K Q1 '22: 965K Q2 '22: 1.3M Q3 '22: 1.5M Q4 '22: 2.1M Q1 '23: 3.7M Q2 '23: 1.4M Q3 '23: 2.7M Q4 '23: 4.4M Q1 '24: 4.8M Q2 '24: 5M Q3 '24: 4.4M Q4 '24: 3.7M Q1 '25: 3.3M Q2 '25: 2.8M Q3 '25: 1.1M Q4 '25: 617K Q1 '26: 1.1M Q2 '26: 1.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 800K 1.6M 2.4M Q3 '21: 350K Q4 '21: 323K Q1 '22: 521K Q2 '22: 623K Q3 '22: 752K Q4 '22: 965K Q1 '23: 1.8M Q2 '23: 819K Q3 '23: 1.4M Q4 '23: 2.1M Q1 '24: 2.2M Q2 '24: 2.1M Q3 '24: 1.7M Q4 '24: 1.8M Q1 '25: 1.5M Q2 '25: 1.4M Q3 '25: 372K Q4 '25: 128K Q1 '26: 458K Q2 '26: 675K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -1.5M Q4 '21: -1.8M Q1 '22: -1.7M Q2 '22: -1.3M Q3 '22: -943K Q4 '22: -1.4M Q1 '23: -477K Q2 '23: -1.6M Q3 '23: -1.5M Q4 '23: -1M Q1 '24: -763K Q2 '24: -890K Q3 '24: -1.1M Q4 '24: -1.6M Q1 '25: -1.9M Q2 '25: -1.8M Q3 '25: -7.2M Q4 '25: -4M Q1 '26: -3.2M Q2 '26: -3.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -1.4M Q4 '21: -1.8M Q1 '22: -1.5M Q2 '22: -1.3M Q3 '22: -847K Q4 '22: -1.4M Q1 '23: -494K Q2 '23: -1.6M Q3 '23: -1.5M Q4 '23: -1M Q1 '24: -775K Q2 '24: -780K Q3 '24: -1.1M Q4 '24: -1.7M Q1 '25: -1.9M Q2 '25: -1.9M Q3 '25: -7.2M Q4 '25: -4.1M Q1 '26: -3.4M Q2 '26: -4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 1M 2M 3M Q3 '21: 362K Q4 '21: 465K Q1 '22: 444K Q2 '22: 702K Q3 '22: 748K Q4 '22: 1.1M Q1 '23: 1.9M Q2 '23: 627K Q3 '23: 1.2M Q4 '23: 2.3M Q1 '24: 2.5M Q2 '24: 2.9M Q3 '24: 2.6M Q4 '24: 1.9M Q1 '25: 1.8M Q2 '25: 1.4M Q3 '25: 731K Q4 '25: 489K Q1 '26: 657K Q2 '26: 573K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -908K Q4 '21: -975K Q1 '22: -1.1M Q2 '22: -724K Q3 '22: -939K Q4 '22: 41K Q1 '23: -43K Q2 '23: -1.5M Q3 '23: -836K Q4 '23: -2K Q1 '24: 481K Q2 '24: -151K Q3 '24: -1.6M Q4 '24: -1.9M Q1 '25: -1.8M Q2 '25: -2.1M Q3 '25: -2.8M Q4 '25: -1.6M Q1 '26: -2.9M Q2 '26: -3.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '11: -333.4K Q4 '11: -381.9K Q1 '18: -1M Q3 '11 Q4 '11 Q1 '18

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 168.9M Q2 '20: 181.6M Q3 '20: 210.2M Q1 '21: 233.7M Q2 '21: 243.7M Q3 '21: 252.9M Q1 '22: 260.8M Q2 '22: 265.9M Q3 '22: 270.7M Q1 '23: 280.7M Q2 '23: 284.9M Q3 '23: 287.9M Q1 '24: 294.3M Q2 '24: 296.4M Q3 '24: 300.5M Q1 '25: 301.3M Q2 '25: 303.2M Q3 '25: 309M Q1 '26: 318.7M Q2 '26: 321M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q3 '21: -0.04 Q4 '21: -0.04 Q1 '22: -0.04 Q2 '22: -0.04 Q3 '22: -0.03 Q4 '22: -0.03 Q1 '23: -0.02 Q2 '23: -0.02 Q3 '23: -0.02 Q4 '23: -0.01 Q1 '24: -0.01 Q2 '24: -0.01 Q3 '24: -0.00 Q4 '24: -0.01 Q1 '25: -0.01 Q2 '25: -0.01 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.04 Q2 '26: -0.05 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.